rs138726443

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_002016.2(FLG):​c.7339C>T​(p.Arg2447*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00389 in 1,613,514 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.0030 ( 1 hom., cov: 29)
Exomes 𝑓: 0.0040 ( 14 hom. )

Consequence

FLG
NM_002016.2 stop_gained

Scores

1
6

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:26O:1

Conservation

PhyloP100: -4.90
Variant links:
Genes affected
FLG (HGNC:3748): (filaggrin) The protein encoded by this gene is an intermediate filament-associated protein that aggregates keratin intermediate filaments in mammalian epidermis. It is initially synthesized as a polyprotein precursor, profilaggrin (consisting of multiple filaggrin units of 324 aa each), which is localized in keratohyalin granules, and is subsequently proteolytically processed into individual functional filaggrin molecules. Mutations in this gene are associated with ichthyosis vulgaris.[provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 54 pathogenic variants in the truncated region.
PP5
Variant 1-152307547-G-A is Pathogenic according to our data. Variant chr1-152307547-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 50932.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-152307547-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FLGNM_002016.2 linkuse as main transcriptc.7339C>T p.Arg2447* stop_gained 3/3 ENST00000368799.2 NP_002007.1 P20930

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FLGENST00000368799.2 linkuse as main transcriptc.7339C>T p.Arg2447* stop_gained 3/31 NM_002016.2 ENSP00000357789.1 P20930

Frequencies

GnomAD3 genomes
AF:
0.00302
AC:
458
AN:
151616
Hom.:
1
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.000722
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00250
Gnomad FIN
AF:
0.00766
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00447
Gnomad OTH
AF:
0.00241
GnomAD3 exomes
AF:
0.00282
AC:
710
AN:
251408
Hom.:
1
AF XY:
0.00284
AC XY:
386
AN XY:
135878
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00199
Gnomad FIN exome
AF:
0.00624
Gnomad NFE exome
AF:
0.00421
Gnomad OTH exome
AF:
0.00228
GnomAD4 exome
AF:
0.00398
AC:
5818
AN:
1461778
Hom.:
14
Cov.:
93
AF XY:
0.00392
AC XY:
2851
AN XY:
727188
show subpopulations
Gnomad4 AFR exome
AF:
0.000747
Gnomad4 AMR exome
AF:
0.000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00195
Gnomad4 FIN exome
AF:
0.00723
Gnomad4 NFE exome
AF:
0.00452
Gnomad4 OTH exome
AF:
0.00313
GnomAD4 genome
AF:
0.00302
AC:
458
AN:
151736
Hom.:
1
Cov.:
29
AF XY:
0.00279
AC XY:
207
AN XY:
74136
show subpopulations
Gnomad4 AFR
AF:
0.00104
Gnomad4 AMR
AF:
0.000721
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00251
Gnomad4 FIN
AF:
0.00766
Gnomad4 NFE
AF:
0.00447
Gnomad4 OTH
AF:
0.00238
Alfa
AF:
0.00302
Hom.:
0
Bravo
AF:
0.00249
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00454
AC:
39
ExAC
AF:
0.00305
AC:
370
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00403
EpiControl
AF:
0.00409

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:26Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ichthyosis vulgaris Pathogenic:10
Pathogenic, criteria provided, single submitterclinical testingCentogene AG - the Rare Disease CompanyJun 08, 2020- -
Likely pathogenic, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Pathogenic, no assertion criteria providedcurationReproductive Health Research and Development, BGI GenomicsJan 06, 2020NM_002016.1:c.7339C>T in the FLG gene has an allele frequency of 0.006 in European(non-Finnish) subpopulation in the gnomAD database.This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. It has been reported multiple times in association with ichthyosis vulgaris and atopic dermatitis as one of the most prevalent FLG pathogenic variants among Northern Europeans (PMID: 17417636; 19874431; 27363669). Taken together, we interprete this variant as Pathogenic/Likely pathogenic variant. ACMG/AMP criteria applied: PVS1; PM2; PS4. -
Pathogenic, criteria provided, single submitterclinical testingUndiagnosed Diseases Network, NIHNov 10, 2016- -
Pathogenic, criteria provided, single submitterclinical testingMendelicsMay 04, 2022- -
Pathogenic, criteria provided, single submitterclinical testingClinical Genomics Laboratory, Washington University in St. LouisNov 07, 2023The FLG c.7339C>T (p.Arg2447Ter) variant has been reported in several individuals affected with ichthyosis vulgaris and atopic dermatitis and is reported in a compound heterozygous state with a pathogenic or likely pathogenic variant in at least at least one individual, and in a heterozygous state in over 100 individuals (González-Tarancón R et al., PMID: 31637781; Greisenegger E et al., PMID: 19874431; Gruber R et al., PMID: 19785597; Sandilands A et al., PMID: 17417636; Schuttelaar M et al., PMID: 19839980; Timmerman JG et al., PMID: 26451970; Weidinger S et al., PMID: 18396323). The highest population minor allele frequency in the population database genome aggregation database (v.2.1.1) is 0.65% in the European (non-Finnish) population. This variant has been reported in the ClinVar database as a pathogenic variant by 18 submitters and likely pathogenic by one submitter. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingLaboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert EinsteinAug 19, 2022ACMG classification criteria: PVS1 very strong, PS4 strong, BS1 strong -
Pathogenic, criteria provided, single submitterclinical testingPittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical CenterOct 24, 2023This sequence variant is a single base substitution (C>T) at coding nucleotide 7339 that replaces an arginine codon with a premature termition sigl in exon 3 of 3 of the FLG gene. This variant is expected to truncate the FLG encoded profilaggrin protein, thereby disrupting the filaggrin 7 repeat and elimiting the remaining filaggrin repeats and C termil domain (PMID: 17502856). Loss of the C termil domain prevents processing profilaggrin into filaggrin monomers, generating a loss of function variant (PMID: 17417636, 22071473). This previously reported (ClinVar 50932), well-documented variant is associated with dermatitis and ichthyosis vulgaris (PMID: 17417636, 19874431, 27363669, 31637781, 32066784, 31365035, 33715246). This variant is present in 814/282684 alleles (0.3%), including 1 homozygote, in the gnomAD control population dataset. Protein studies on p.R501Ter/p.R2447Ter compound heterozygous cell lysates showed that profilaggrin was greatly reduced and filaggrin was absent (PMID: 17417636). Given this information, we consider this a pathogenic variant. ACMG Criteria: PS3, PVS1 -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsJan 13, 2024- -
Pathogenic, no assertion criteria providedclinical testingClinical Genetics Laboratory, University Hospital Schleswig-HolsteinMay 18, 2021- -
not provided Pathogenic:9
Pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely pathogenic, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalAug 15, 2023- -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024FLG: PM3:Very Strong, PVS1:Strong, PM2:Supporting -
Pathogenic, criteria provided, single submitterclinical testingInstitute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU DresdenMar 07, 2023PVS1, PS3 -
Likely pathogenic, criteria provided, single submitterclinical testingCentre for Clinical Genetics and Genomic Diagnostics, Zealand University HospitalFeb 02, 2024- -
Pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 22, 2020Recurrent variant that has been reported multiple times in association with ichthyosis vulgaris and atopic dermatitis as one of the more prevalent FLG pathogenic variants among Northern Europeans (Sandilands et al., 2007; Greisenegger et al., 2010; Gimalova et al., 2016); Nonsense variant in the C-terminus predicted to result in protein truncation; other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 26451970, 17417636, 31365035, 19874431, 19839980, 22951058, 19785597, 22995991, 21377035, 28213896, 27363669, 29068602, 29428354, 29054605, 30665703, 31589614, 33144682) -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Medical Genetics and Applied Genomics, University Hospital TübingenOct 23, 2020- -
Pathogenic, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Dermatitis, atopic, 2 Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterJan 06, 2020- -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, Clinical Exome/Genome Diagnostics Group, University Hospital BonnAug 20, 2021PVS1, PS2, BS2 -
Pathogenic, criteria provided, single submitterclinical testingCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterMar 25, 2024- -
Ichthyosis vulgaris;C1853965:Dermatitis, atopic, 2 Pathogenic:2Other:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant classified as Pathogenic and reported on 09-09-2020 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Pathogenic, criteria provided, single submitterclinical testingJuno Genomics, Hangzhou Juno Genomics, Inc-PM2_Supporting+PVS1_Strong+PS4+PP4 -
FLG-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaSep 02, 2021The FLG c.7339C>T (p.Arg2447Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. Across a selection of the available literature, the p.Arg2447Ter variant has been identified in a heterozygous state in at least 32 individuals with atopic dermatitis (Weidinger et al. 2008; Greisenegger et al. 2009; Gimalova et al. 2016; González-Tarancon et al. 2020). The p.Arg2447Ter variant was also reported in a heterozygous state in 28 matched population control subjects, and is reported at a frequency of 0.006488 in the European (Finnish) population of the Genome Aggregation Database (version 2.1.1). This allele frequency is high but is consistent with high prevalence and variable severity seen in affected individuals. Based on the evidence, the p.Arg2447Ter variant is classified as pathogenic for FLG-related disorders. -
Dermatitis, atopic Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGM-The observed stop gained variant c.7339C>T(p.Arg2447Ter) in FLG gene has been reported in heterozygous state in multiple individuals with Ichthyosis vulgaris and atopic dermatitis. This recurrent variant is one of the more prevalent FLG pathogenic variants among Northern Europeans (González-Tarancón R, et al., 2020, Gimalova et al., 2016). The c.7339C>T variant has 0.2% allele frequency in gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic (multiple submissions). This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing (González-Tarancón R, et al., 2020). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.021
T
BayesDel_noAF
Pathogenic
0.20
CADD
Pathogenic
35
DANN
Benign
0.97
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.71
FATHMM_MKL
Benign
0.0047
N
Vest4
0.36
GERP RS
-2.9

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138726443; hg19: chr1-152280023; API